{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Current and Evolving Treatments for Myositis","description":"For years, myositis treatment has relied on broad immune suppression with drugs like steroids, methotrexate, and rituximab\u2014but what if we could target the disease more precisely? Inflammatory myopathies are not a single condition, but a group of biologically distinct syndromes with different clinical features and immune pathways. As our understanding evolves, so does the potential for more personalized, targeted therapies. In this episode,&amp;nbsp;we\u2019re&amp;nbsp;joined by Dr. Julie J. Paik to discuss how this shift could reshape the future of myositis treatment.&amp;nbsp; ","author_name":"ACR on Air","author_url":"https:\/\/www.rheumatology.org\/Learning-Center\/Publications-Communications\/Podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40564970\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/006fba\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/40564970"}